SG/CALL/ABBVIE/190/0.1/20.12.24 Share Price

DE000SU6FCC1

Market Closed - Bid/Ask 01:09:51 25/06/2024 am IST			Pre-market 11:36:10 am
0.43 ^EUR	+4.88%		0.435	+1.16%

Current month	+126.32%
1 month	+152.94%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ABBVIE INC.

Latest news about ABBVIE INC.

AbbVie Declares Quarterly Dividend	24/06	AQ
AbbVie Keeps Quarterly Dividend at $1.55 per Share, Payable Aug. 15 to Shareholders of Record July 15	21/06	MT
AbbVie Declares Quarterly Dividend	21/06	PR
AbbVie Inc. Declares Quarterly Cash Dividend, Payable on August 15, 2024	21/06	CI

More news

Quotes 5-day view

Date	Price	Change
24/24/24	0.43	+4.88%
21/24/21	0.41	-8.89%
20/24/20	0.45	+12.50%
19/24/19	0.4	-6.98%
18/24/18	0.43	+10.26%

Real-time Boerse Frankfurt Warrants

Last update June 25, 2024 at 01:09 am IST

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	ABBVIE INC.
Issuer	Société Générale
WKN	SU6FCC
ISIN	DE000SU6FCC1
Date issued	29/12/2023
Strike	190 $
Maturity	20/12/2024 (179 Days)
Parity	10 : 1
Emission price	0.28 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	1.1 €
Lowest since issue	0.13 €
Delta	0.3x
Omega	11.14
Premium	12.73x
Gearing	36.57x
Moneyness	0.9092
Difference Strike	17.26 $
Difference Strike %	+9.08%
Spread	0.02 €
Spread %	4.44%
Theoretical value	0.4400
Implied Volatility	21.45 %
Total Loss Probability	73.99 %
Intrinsic value	0.000000
Present value	0.4400
Break even	194.72 €
Theta	-0.02x
Vega	0.04x
Rho	0.02x

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).

Sector

More about the company